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Brain-derived neurotrophic factor (BDNF) signaling is
implicated in the etiology of many psychiatric disorders
associated with altered emotional processing. Altered
peripheral (plasma) BDNF levels have been proposed
as a biomarker for neuropsychiatric disease risk in
humans. However, the relationship between peripheral
and central BDNF levels and emotional brain activation
is unknown. We used heterozygous BDNF knockdown
rats (BDNF+/−) to examine the effects of genetic variation
in the BDNF gene on peripheral and central BDNF levels
and emotional brain activation as assessed by awake
functional magnetic resonance imaging (fMRI). BDNF+/−
and control rats were trained to associate a ﬂashing light
(conditioned stimulus; CS) with foot-shock, and brain
activation in response to the CS was measured 24h later
in awake rats using fMRI. Central and peripheral BDNF
levels were decreased in BDNF+/− rats compared with
control rats. Activation of fear circuitry (amygdala, peri-
aqueductal gray, granular insular) was seen in control
animals; however, activation of this circuitry was absent
in BDNF+/− animals. Behavioral experiments conﬁrmed
impaired conditioned fear responses in BDNF+/− rats,
despite intact innate fear responses. These data conﬁrm
a positive correlation [r =0.86, 95% conﬁdence interval
(0.55, 0.96); P = 0.0004] between peripheral and cen-
tral BDNF levels and indicate a functional relationship
between BDNF levels and emotional brain activation as
assessed by fMRI. The results demonstrate the use of
rodent fMRI as a sensitive tool for measuring brain func-
tion in preclinical translational studies using genetically
modiﬁed rats and support the use of peripheral BDNF as
a biomarker of central affective processing.
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Brain-derived neurotrophic factor (BDNF) is a widely
expressed neurotrophin that signals through the
tropomyosin-related kinase B receptor (TrkB) to exert effects
on neurogenesis, neuroprotection and synaptic plasticity
(Poo 2001). In humans, reduced BDNF function is implicated
in the pathophysiology of a range of neurological, affective
and psychiatric disorders, including major depressive disor-
der, post-traumatic stress disorder (PTSD) and schizophrenia
(e.g. Schumacher et al. 2005; Weickert et al. 2003). In
particular, altered levels of peripheral (serum) BDNF have
been found in patients with depression, generalized anxiety
disorder and PTSD, supporting BDNF’s potential role as a
biomarker for disease (Fernandes et al. 2014; Matsuoka et al.
2013; Wang et al. 2015). However, the relationship between
peripheral BDNF levels, central BDNF levels and emotional
brain function is currently unclear and is highly challenging to
study directly in humans.
There is evidence that rats may be a particularly appropriate
species with which tomodel key aspects of BDNF physiology
of relevance to human disorders. Firstly, BDNF is present in
the serum of humans and rats, but not of mice (Klein et al.
2011). This is an important difference given that serum BDNF
levelsmay prove to be useful biomarkers of risk for psychiatric
diseases in humans. And secondly, the larger brain size of rats
makes them more tractable for certain physiological studies
including brain imaging (Brydges et al. 2013).
Pavlovian fear conditioning is a robust method for studying
emotional learning in rodents. Pavlovian fear associations are
acquired by pairing a neutral stimulus (conditioned stimulus;
CS e.g. a tone/visual cue or context) with an intrinsically aver-
sive stimulus (unconditioned stimulus, US, e.g. foot-shock)
resulting in conditioned responding to subsequent presen-
tations of the CS. Previous fear-conditioning studies in rats
and transgenic mice have revealed a key role for central
BDNF in fear conditioning (Endres & Lessmann 2012; Hall
et al. 2000; Liu et al. 2004; Rattiner et al. 2004; Soliman et al.
2010). Given the relevance of BDNF to human emotional dis-
orders and the translational potential of transgenic rats, in
this study, we investigated emotional learning in a genetically
modiﬁed rat model of reduced BDNF expression.
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Functional magnetic resonance imaging (fMRI), which
uses changes in cerebral blood ﬂow and oxygenation to
provide a proxy for neuronal activation, is a potentially
powerful translatable marker of brain function. fMRI has
been used to investigate the neural underpinnings of affec-
tive disorders that associate with BDNF polymorphisms
in humans (Egan et al. 2003; Montag et al. 2008; Soliman
et al. 2010). In particular, fMRI has revealed that humans
with BDNF polymorphisms have altered fear processing
during fear-conditioning paradigms (Soliman et al. 2010).
We have developed fMRI methods for investigating brain
responses to fear-conditioned stimuli in awake rodents
(Brydges et al. 2013; Harris et al. 2015). Here, we apply
this approach to investigate the effect on brain activation of
genetic knockdown of BDNF in transgenic rats.
Based on previous studies we predicted: (1) decreased
peripheral and central BDNF levels in BDNF+/− rats compared
with littermate control rats, (2) decreased emotional learning
in BDNF+/− rats and (3) decreased activation of brain regions
involved in emotional learning in response to conditioned
stimuli presented during awake fMRI in BDNF+/− rats, in
particular the amygdala and insular regions (Brydges et al.
2013; Harris et al. 2015). Overall, this study aimed to provide
a clearer understanding of the impact of genetic variation in
BDNF on peripheral and central BDNF levels and emotional
brain function.
Methods and materials
Animals: genotyping and husbandry
Animals were bred in-house by crossing male rats heterozygous
for a BDNF knockdown mutation (HET, SD-BDNFtm1sage) generated
using zinc ﬁnger nuclease technology (SAGE®Labs, St Louis, MO,
USA) on a Sprague–Dawley (Hsd:SD) background with control female
Sprague–Dawley rats (SAGE®Labs, St Louis, MO, USA). Resultant
litters comprised of BDNF+/+ rats (controls) and heterozygous BDNF
knockdown rats (BDNF+/−) in a 1:1 ratio. Genotype was determined
from a small ear biopsy taken at weaning following the protocol of
SAGE®Labs. The experimenter was blind to genotype throughout the
experiment.
BDNF+/− and control (male rats only), weighing 300±20g (approx-
imately 10 weeks old) at the start of the experiment, were housed
in small groups (3–4 mixed genotypes per cage) with water and
standard chow available ad libitum, in a humidity (50–60%) temper-
ature (21∘C) and light (on 0700–1900h) controlled environment. All
testing took place during the light phase. Prior to scanning, all rats
were handled daily for 15±5days (15min/day in groups of 4–5 at a
time) to minimize stress associated with handling. Age at scanning
was at least 12weeks. All animal experiments were approved by the
University of Edinburgh Ethical Review Committee, and studies were
carried out in strict accordance with the UK Home Ofﬁce Animals
(Scientiﬁc Procedures) Act 1986 and the European Communities
Council Directive of 22 September 2010 (Directive 2010/63/EU).
Measurement of BDNF and TrkB
Group 1 rats
BDNF protein levels were measured in serum and whole hip-
pocampus from experimentally naïve control and BDNF+/− rats
(n=6/genotype; approximately 15weeks old). Serum was processed
from trunk blood, and whole hippocampus was dissected from the
brain of the same animal (pooled across left and right hemisphere) fol-
lowing decapitation between 0900 and 1200h. Samples were stored
at −80∘C until processing. BDNF protein was measured using a com-
mercially available ELISA kit following the manufacturer’s protocol
(BDNF Emax ImmunoAssay System, Promega Southampton, UK, Cat
No.G7611). See Appendix S1 (Supplementary Information) for sample
preparation details. Serum BDNF levels were calculated as nanogram
per milliliter (ng/ml) and brain levels as nanogram per gram (ng/g) per
wet weight of tissue (ng/g ww). The linear correlation between serum
and hippocampal BDNF protein levels was tested using Pearson’s r
following tests for normality, outliers and equal variance.
Group 2 rats
BDNF protein was measured in amygdala tissue punches (pooled
across left and right hemisphere) from control and BDNF+/− rats
that had been fMRI scanned (n=8 /genotype; culled approximately
2weeks after fMRI) using the same ELISA kit as above. Levels are
reported as ng/g per wet weight of tissue (ng/g ww).
Group 3 rats
Hippocampal BDNF and TrkB receptor mRNA levels were measured
in a separate cohort of experimentally naïve rats (n=6 control and 8
BDNF+/− 15 weeks old). Hippocampal RNA was extracted using an
RNeasy mini kit (Qiagen, Manchester, UK, cat No. 74104) following
the manufacturers protocol and real time PCR was carried out on
cDNA using a LightCycler 480 (Roche Diagnostics, Burgess Hill,
UK) with a commercial master mix (FAM-hydrolysis probe, Roche
Diagnostics). See Appendix S1 for primer and probe details. Data
from all three groups were normally distributed, had equal variance,
no outliers and were analyzed using unpaired two-sided t-tests.
Fear-conditioning protocol
We initially conﬁrmed that foot-shock sensitivity was matched
between genotype groups (See Fig. S1). Then behavioral assess-
ment of fear conditioning was assessed in a cohort of animals
not used for fMRI (n= 11 control; n= 17 BDNF+/− rats). Rats were
placed in the conditioning chamber (30× 25× 32 cm, Coulbourn
Instruments, Whitehall, PA, USA) and over the course of a 25-min
period were exposed to ﬁve pairings (every 5±1min) of the CS:
a 10 second ﬂashing blue light (5Hz max intensity ﬂashes, 50/50
duty cycle) that co-terminated with the US: a 0.5 second, 0.8mA
foot-shock delivered through the grid ﬂoor. Percentage of time spent
freezing during the inter shock intervals (ISI) was measured manu-
ally, directly and continuously and analyzed by repeated measures
analysis of variance (RM ANOVA).
The conditioned response was assessed by measuring percentage
of time freezing in response to the CS 24h later in a novel context.
The CSwas presented (ﬂashing light identical to training) for 2min fol-
lowed by 2min rest (i.e. no light), repeated a total of 3 times. Freezing
was measured manually, directly and continuously throughout each
2min CS and rest period. The percentage time freezing during CS
and rest periods was normally distributed and had equal variances
and was analyzed by RM ANOVA.
fMRI: acclimatization to the MRI scanning
environment
Prior to fMRI scanning, rats were acclimatized to the head and body
restraint [Animal Imaging Research MRI (AIRMRI) Westminster, CA,
USA; formerly InsightMRI; see Appendix S1 for details of the restraint
apparatus) and MRI pulse sequence noise (120 dB) in mock scans
that took place in a custom built mock scanner and lasted 30min on
days 1 and 3 (Brydges et al. 2013; King et al. 2005). Conditioning was
conducted as described above on day 4. fMRI scanning took place
in the MRI scanner on day 5 (See Fig. 1 for experimental timeline).
For mock and MRI scanning, rats were lightly anesthetized (2–3%
isoﬂurane in air and oxygen; 50:50 at 1 l/min) while placed in and out
of the restraint apparatus. The rat in the restraint apparatus was then
placed in the bore of the mock or MRI scanner as appropriate.
fMRI: image acquisition
In total, 13 BDNF+/− and 14 control rats were scanned (sample
size based on previous rodent fMRI studies which revealed signiﬁ-
cant fear circuitry activation (Brydges et al. 2013; Harris et al. 2015).
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Figure 1: Experimental timeline. Rats were ‘mock scanned’
on days 1 and 3, fear conditioned on day 4 and retrieval of the
conditioned fear response took place 24 h later during fMRI on
day 5. The sound level (in dB) of the pulse sequence is given.
Twenty-four hours after cued fear conditioning, rats were placed into
the restraint apparatus. An adjustable surface coil was ﬁxed inside
the head restraint and pressed ﬁrmly on the rat’s head and locked
in place. The rat was then placed into a 7 T MRI scanner (Agilent
Technologies, Oxford, UK) equipped with a 400 mT/m gradient set,
a 72mm volume RF coil for transmission and a surface coil for signal
reception (AIRMRI). Structural images were acquired under 2–3%
isoﬂurane using fast spin echo (FSE) sequence with a matrix of
256× 256, ﬁeld of view 30mm (in plane resolution 117 μm), repeti-
tion time=3000ms, echo train length 8, effective echo time=48ms,
4 signal averages and 26×1mm coronal slices and took 12min
to acquire. Animals were then allowed to recover from anesthesia
(breathing rate>100/min, which typically took approximately 10min)
before beginning the functional scanning paradigm. Isoﬂurane is
rapidly eliminated from the body (Ferris et al. 2006) and the ﬁrst
CS exposure occurred 15–17min following isoﬂurane withdrawal.
If isoﬂurane effects were still present in the brain following with-
drawal (e.g. Thrane et al. 2012), these effects would be similar in the
BDNF+/− and control rats. Once awake, functional scanning began
and after a 5min acclimatization period the CS was presented in
the scanner using a custom built array of high intensity blue LEDs.
The test paradigm consisted of 2min ﬂashing light (CS) alternating
with 2min ‘rest’ period (during which the CS was not presented)
this was repeated a total of three times (without any shocks being
administered) with randomized starting order. Functional image acqui-
sition used an FSE sequence with a matrix of 64× 64 (in plane reso-
lution 469 μm), repetition time=2500ms, echo train length 16 and
effective echo time=36ms. Each functional volume consisted of
16×1mm slices covering the brain (excluding the cerebellum) and
took 10 seconds to acquire. Functional scanning was run for a total of
103 volumes and took 17min and 10 seconds to complete.
fMRI: data preprocessing and analysis
SPM8 (Wellcome Trust Centre for NeuroImaging, University College
London, UK) was used for image analysis. To facilitate analysis in
SPM8, all images were scaled up by a factor of 10 in the x, y and
z dimensions to account for the relative size difference between
human and rat brain. For each rat, functional images were realigned
to remove minor motion, and a mean functional volume generated.
(At this stage, two control rats were removed from the analysis
due to translational movement >1.5mm and rotational movement
>5 mrads; displacement was calculated as detailed (Van Dijk et al.
2012). Levels of displacement did not differ between genotypes; see
Table S1). The rat’s structural image was then co-registered to the
correspondingmean functional image. Segmentation of the structural
image, using tissue probability maps for gray and white matter and
cerebrospinal ﬂuid (Valdes-Hernandez et al. 2011) was then combined
with spatial normalization to the template using a resampled voxel
size of 2× 2× 2mm to match the template (Valdes-Hernandez et al.
2011), and the same normalization parameters were applied to the
functional images. Finally, all realigned and normalized images were
smoothed with a 6× 6×6mm full width at half maximum Gaussian
ﬁlter to increase signal to noise and allow for small anatomical and
functional variations between rats (Mikl et al. 2008).
First level analysis was performed on all rats using a general linear
model in SPM8. The three CS presentationsweremodeled as a single
regressor and the 5min acclimatization period and rest periods were
modeled as an implicit baseline in the model. Parametric modulation
was used to model a linear decrease from the ﬁrst CS to the third CS
to investigate any increase or decrease in activation. All data were
modeled by a boxcar convolved with the SPM8 canonical haemody-
namic response function. Movement parameters generated in the
re-alignment step were added in to the model as multiple regressors
and event-dependent high-pass ﬁltering was used whereby the cutoff
period was 580 seconds. Temporal autocorrelation was accounted for
using the AR(1) whitening model of SPM8. Parameter images corre-
sponding to the CS>baseline regressor were entered into a second
level random effects model, in which within group effects (e.g.
CS>baseline; CS1>CS3) were examined using one-sample t-test
and between group effects (e.g. control>BDNF+/−) were examined
using a two sample t-test. Whole brain group level statistical para-
metric maps (SPMs) had cluster forming thresholds of P <0.001,
and clusters were considered signiﬁcant at P <0.05 corrected for
multiple comparisons using cluster level correction based on random
ﬁeld theory (PFWE: family wise error corrected P value). SPMs are
presented overlaid onto an average structural image (created using
the average of all normalized structural images from this study). The
cluster level PFWE; number of voxels within the cluster; peak T value
and co-ordinates in x, y and z dimensions of the peak voxel within
the cluster are reported. The co-ordinates (millimeters) refer to the
Bregma coordinate system (the origin point is where Bregma zero
intersects with the center of the anterior commissure, n.b. data are
scaled by 10; x= left/right, y= anterior/posterior, z= ventral/dorsal).
Unthresholded activation maps were generated to investigate
visual activation in response to the CS. These maps show the raw
effect size for each voxel and thus show all regions (uncorrected for
multiple comparisons) for which there was some activation (Jernigan
et al. 2003), but because these clusters do not pass the strict FWE
cluster correction used here, they cannot be reported as signiﬁcant.
Correlation between amygdala BDNF level
and amygdala function
To investigate the relationship between amygdala activation and
amygdala BDNF levels, parameter estimates (ﬁrst eigenvalues) were
extracted from the functional cluster over the left amygdala (using
contrast CS>baseline for control rats) and then correlated with
the corresponding amygdala BDNF level. The parameter estimates
represent an estimate of the relative response amplitude of neural
activations elicited during the different conditions (e.g. CS>baseline;
baseline=0).
Laterality and habituation of amygdala activation
to the CS
To explicitly investigate laterality and habituation of amygdala activa-
tion across the three CS presentations, a second GLM was used to
model the three CS as separate regressors and the rest periods as
an implicit baseline. Anatomically deﬁned masks (covering the whole
left and right amygdala complex) were created using MRIcro (Rorden
& Brett 2000) using the Paxinos and Watson Atlas as a guide (Pax-
inos & Watson 2004). The parameter estimates (ﬁrst eigenvalues)
were then extracted per region of interest. The parameter estimates
from the ﬁrst, second and third CS presentations for the control and
BDNF+/− rats were then analyzed by RM ANOVA, genotype was a
main effect and CS presentation (CS1, 2, 3) and hemisphere (left/right)
were repeated measures.
Elevated plus maze
Innate anxiety was measured in a separate cohort of rats (n=10
control; n=11 BDNF+/− rats; 16weeks old) in an elevated plus maze
between 0900 and 1500h. Rats were placed individually on the maze
and left to explore for 5min (maze and protocol details; Brydges et al.
2012). Behavior was recorded using ANY-maze tracking software
(ANY-maze, Stoelting Co., Wood Dale, IL, USA). The percentage time
in the open arms, percentage distance moved in the open arms and
number of crossings into the open arms over the 5min trial was com-
pared between the genotypes by unpaired two-sided t-test. A blood
sample was taken, in a separate room, by tail nick and collected in a
tube pretreated with ethylenediaminetetraacetic acid immediately
following EPM testing for plasma corticosterone measurement
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Table 1: BDNF protein in serum, hippocampus and amygdala
homogenates and BDNF and TrkB receptor mRNA levels in
hippocampal homogenates (± SEM)
Parameter
Control
rats
BDNF+/−
rats
Serum BDNF protein (ng/ml) 1.1± 0.1 0.3±0.04***
Hippocampal BDNF protein (ng/g ww) 3.6± 0.1 2.5±0.2***
Amygdala BDNF protein (ng/g ww) 2.9± 0.3 1.6±0.4*
Hippocampal BDNF mRNA (AU) 0.9± 0.1 0.9±0.1
Hippocampal TrkB mRNA (AU) 1.1± 0.1 1.3±0.1
AU, arbitrary units.
*P <0.05 unpaired t-test; ***P <0.001.
using an in-house radioimmuno-assay using [3H]-corticosterone
(assay details; Aldujaili et al. 1981). All data were normally distributed
and had equal variance and were analyzed using unpaired two-sided
t-test.
Results
BDNF and TrkB levels
Serum BDNF protein levels were 73% lower in BDNF+/−
rats compared with control rats [−0.87 ng/ml; 95% CI (−1.2,
−0.59); t10 = 6.8, P <0.0001; Table 1]. Central BDNF protein
levels were also signiﬁcantly lower in BDNF+/− compared
with control rats; 31% lower in the hippocampus [−1.1 ng/g
ww; 95% CI (−1.5, −0.7); t10 =5.6, P =0.0002; Table 1], and
45% lower in the amygdala [−1.3 ng/g ww; 95% CI (−2.3,
−0.3); t11 = 2.8, P =0.017, Table 1]. There was a signiﬁcant
positive correlation between serum and hippocampus BDNF
levels [Pearson’s correlation coefﬁcient: r = 0.86, 95% CI
(0.55, 0.96); P =0.0004; see Fig. S2a]. The mRNA levels of
BDNF and TrkB in the hippocampus did not differ between
the genotypes (P >0.05; Table 1).
BDNF+/− rats have an impaired freezing response
to a cued CS
During acquisition of the cued fear-conditioning freez-
ing during the ISI signiﬁcantly increased in both control
littermate and BDNF+/− rats (main effect of ISI: F5,110 =78.9,
P <0.0001; Fig. 2a). During retrieval, 24 h after cued fear
conditioning, all rats showed increased freezing behavior
in response to CS presentation conﬁrming that control
and BDNF+/− rats detected the visual stimulus, however,
the response to the ﬁrst CS was signiﬁcantly reduced in
the BDNF+/− rats compared with controls (genotype-by-CS
interaction: F2,48 =12.5, P < 0.0001; Tukey HSD post hoc for
CS1: P <0.05; Fig. 2b). The control rats showed a signiﬁ-
cant decrease in freezing over the 3 CS presentations (CS
presentation: F2,20 =7.9, P = 0.003; Fig. 2b).
Control rats activate fear circuitry in response
to a cued CS
In the fMRI experiment, within group analysis of the control
rats revealed one large cluster of activation which extended
over the left amygdala (encompassing the basolateral,
medial and lateral nuclei), into the hypothalamus region and
up into the left granular insular and somatosensory cortex,
key regions implicated in processing fear [PFWE <0.0001,
KE =853, peak T= 8.55 at (38, −16, −2); Fig. 3a; Table 2].
The primary visual cortex, superior colliculus, bed nucleus
of the stria terminalis, restrosplenial dysgranular cortex and
caudate putamen were also activated during the CS pre-
sentations (Fig. 3b and 3c; Table 2). No signiﬁcant clusters
of activation were found when modeling a linear decrease
in brain activation from CS1 to CS3 using parametric mod-
ulation. The within group analysis of the BDNF+/− rats in
response to the CS revealed no signiﬁcant fear circuitry
and no signiﬁcant clusters of activation were found when
modeling a linear decrease in brain activation from CS1 to
CS3 using parametric modulation.
Unthresholded activation maps revealed that the superior
colliculus and the primary visual cortex were activated in
response to the CS in the control and BDNF+/− rats (Fig. 3d).
Furthermore, parameter estimates extracted from the pri-
mary visual cortex and superior colliculus did not signiﬁcantly
differ between control and BDNF+/− (Table S2) supporting
activation of visual processing regions in both groups, but
since the clusters in the BDNF+/− rats did not pass the strict
FWE cluster correction used here, they cannot be reported
as signiﬁcant.
Figure 2: Behavioral assessment of cued fear conditioning. (a) Percentage time freezing (± SEM) during acquisition of cued fear
conditioning before the ﬁrst shock (pre) and during the ISI (1–5). (b) Percentage time freezing (± SEM) during retrieval, 24 h after
conditioning. The controls (black bars; n=11) spent signiﬁcantly longer freezing in response to the ﬁrst presentation of the CS than the
BDNF+/− rats (white bars; n=17; * Tukey HSD post hoc P <0.05).
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Figure 3: SPMs of brain activation (BOLD signal) in response to the CS versus baseline in control rats (n=12) and unthresh-
olded activation maps for control and BDNF+/− rats. (a) A signiﬁcant cluster was found over the left anterior amygdala [A;
PFWE <0.0001, KE = 853, peak T=8.55 at (38,−16,−2)], (b) the right primary visual cortex and superior colliculus [V1, SC; PFWE <0.0001,
KE = 1568, peak T= 7.45 at (−48, −72, 44)] and (c) bed nucleus of the stria terminalis reaching forward to the right nucleus accumbens
[BNST; PFWE =0.002, KE =327, peak T= 6.71 at (−24, 2, −2)]. Cluster forming threshold: P < 0.001, maps presented overlaid on the
average structural image (n=25), the right side of the image is the left side of the brain. Scale bar represents T-score. (d) Unthresh-
olded activation maps for control (n=12) and BDNF+/− rats (n=13) show activation in the primary visual cortex (V1) and SC in response
to the CS. Color bar represents the raw effect size (increase/decrease) in arbitrary units.
Table 2: Clusters of brain activation (BOLD response) in the control (n=12) and BDNF+/− rats (n= 13)
Cluster statistic PFWE corrected Cluster extent Peak T score in cluster Co-ordinates of peak voxel (mm) Description of region
Control within group (CS>baseline), cluster forming threshold P <0.001
P <0.0001 853 8.55 26, −20, −18 L amygdala, SSC, GI
P =0.003 301 8.00 38, −16, −2 L ant. caudate putamen
P <0.0001 1568 7.45 −48, −72, 44 R primary visual ctx, SC
P <0.0001 452 7.21 −6, −54, 42 RSD ctx
P =0.002 327 6.71 −24, 2, −2 R BNST
Control>BDNF+/− between groups (CS>baseline), cluster forming threshold P <0.001
P =0.001 490 6.49 46, −12, −20 L amygdala
P =0.06 195 5.38 58, 12, −2 L GI
P =0.057 198 4.91 −48, −76, 30 R parasubiculum
P =0.062 193 4.79 6, −52, 38 RSD ctx and PAG
ant, anterior; BNST, bed nucleus of the stria terminalis; ctx: cortex; GI, granular insular cortex; L, left; PAG, periaqueductal gray; R,
right; RSD, retrosplenial dysgranular cortex; RSD ctx, retrosplenial dysgranular cortex; RSGc: retrosplenial granular cortex; SC, superior
colliculus; SSC, secondary somatosensory cortex; T, peak voxel t-statistic.
Coordinates in millimeters refer to the Bregma coordinate system (anterior commissure, n.b. data were scaled by 10).
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Figure 4: SPMs showing brain activation (BOLD signal) in response to the CS versus baseline that was greater in control rats
(n= 12) than in BDNF+/− rats (n=13). (a) Coronal, sagittal and axial views of the cluster over the left amygdala [A; PFWE <0.001,
KE =490, peak T=6.49 at (46, −12, −20)]. (b) Parameter estimates from left and right amygdala across the three CS presentations;
*main effect of genotype P <0.05. (c) The GI [PFWE <0.06, KE =195, peak T=5.38 at (58, 12, −2)], (c) the PAG [PFWE =0.062, KE =193,
peak T=4.79 at (6, −52, 38)] and e) the right parasubiculum [PaS; PFWE = 0.057, KE =198, peak T= 4.91 at (−48, −76, 30)]. SPMs
are presented overlaid on the average structural image (n=25) and the right side of the image is the left side of the brain. Scale bar
represents T-score.
Control rats have greater fear circuitry activation
in response to a cued CS than BDNF+/− rats
We next directly compared brain activation in response to
the CS between control and BDNF+/− rats. Between-group
analysis revealed a highly signiﬁcant cluster covering the left
amygdala complex that showed greater activation in con-
trol than the BDNF+/− rats [PFWE < 0.0001, KE =490, peak
T=6.49 at (42, −10, −22); Fig. 4a; Table 2]. Parameter esti-
mates were also signiﬁcantly higher in the control rats com-
pared to BDNF+/− rats to the CS, irrespective of hemisphere
(main effect of genotype: F1,23 =5.8, P =0.025; Fig. 4b).
The between-group analysis revealed three other clusters
that showed greater activation in control than the BDNF+/−
rats in regions implicated in fear processing, however, these
clusters only reached a trend for statistical signiﬁcance when
corrected for multiple comparisons across the whole brain
(cluster level PFWE <0.06). One cluster was found in the
left granular insular (GI), which comprises a component of
the pain pathway recruited into processing conditioned fear
[PFWE =0.06, KE = 195, peak T= 5.38 at (58, 12, −2); Fig. 4c].
The second cluster was found in the dorsomedial periaque-
ductal gray region (PAG; reaching up into the superior collicu-
lus) which is involved in the processing of defensive behav-
ior (e.g. freezing) in response to the CS [PaS; PFWE =0.062,
KE =193, peak T=4.79 at (42, −10, −22); Fig. 4d]. The third
cluster was found in the right parasubiculum [PFWE =0.057,
KE =198, peak T= 4.91 at (−48, −76, 30); Fig. 4e]. These data
support greater fear circuitry activation in the controls than in
the BDNF+/− rats in response to the CS.
Examination of neural activation that was greater in the
BDNF+/− animals than in control rats in response to the CS did
not reveal any signiﬁcant clusters when corrected for multiple
comparisons across the whole brain. There were no signiﬁ-
cant differences between the genotypes when investigating
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activation that was greater in CS1 than in CS3 (i.e. modeling
extinction).
Amygdala activation correlates with amygdala BDNF
levels
There was a signiﬁcant positive correlation between the
extracted parameter estimates from the functional left amyg-
dala cluster and baseline amygdala BDNF levels [measured
2weeks after fMRI; Pearson’s correlation coefﬁcient r= 0.73,
95% CI for slope (0.3, 0.9); P =0.0044; See Fig. S2b]. This
supports the hypothesis that animals with low basal levels of
BDNF in the amygdala have reduced amygdala activation to
a cued CS.
Laterality and habituation of amygdala activation
to the CS
Parameter estimates extracted from the whole amygdala
region in the left and right hemisphere were not signiﬁ-
cantly different, supporting bilateral amygdala activation to
the CS (effect of hemisphere: F1,23 = 1.7, P = 0.20; Fig. 4b).
All interactions with CS (1–3) and hemisphere were not
signiﬁcant.
Based on the result of the behavioral experiment (in which
control rats displayed reduced freezing in CS3 compared
to CS1; Fig. 2b), parameter estimates from the left amyg-
dala in response to CS1 were compared with CS3 using
paired t-test. There was a trend for decreased left amygdala
activation in control rats (paired t-test: t11 =2.1, P =0.057),
supporting a tendency for amygdala habituation across the
CS presentations.
Spontaneous (unconditioned) anxiety is unchanged
in BDNF+/− rats
There were no signiﬁcant differences between BDNF+/−
and control rats in any of the parameters measured on
the elevated plus maze (Table S3). Levels of the stress
hormone corticosterone, measured immediately following
testing, did not signiﬁcantly differ between the genotypes
(t18 = 0.9, P = 0.37; Table S3). These data suggest equal lev-
els of spontaneous innate anxiety-like behavior and stress
hormone responses in response to stress in BDNF+/− and
control rats.
Discussion
In this study, we show reduced central and peripheral BDNF
levels and impaired emotional brain activation during awake
fMRI in BDNF+/− rats compared with controls. BDNF protein
levels were signiﬁcantly reduced in the serum, hippocampus
and amygdala of BDNF+/− rats relative to controls, with no
accompanying compensatory changes in the BDNF receptor,
TrkB (Gururajana et al. 2014; St. Laurent et al. 2013). In addi-
tion, central BDNF levels strongly correlated with peripheral
BDNF levels. Using awake rat fMRI, we were able to demon-
strate decreased amygdala activation to an emotional condi-
tioned cue in BDNF+/− rats comparedwith controls, reﬂecting
the decrease in amygdala BDNF levels.
It is widely accepted that the amygdala is a critical struc-
ture for the acquisition, storage and expression of learned
fear (LeDoux 2000). Presentation of a cue previously asso-
ciated with foot-shock in our fMRI experiment resulted in the
activation in control animals of a cluster that encompassed
the amygdala complex [basolateral amygdala (BLA) and cen-
tral nucleus (CeA) of the amygdala in the left hemisphere].
The BLA receives sensory information and plays a key role
in forming the CS–US association (reviewed in Maren 2001).
The CeA is then held to mediate the output from the amyg-
dala to downstream structures to coordinate the behavioral
and physiological response to the CS (e.g. freezing, increased
heart-rate). In addition, parameter extracts from the left amyg-
dala showed a tendency to decrease in response to CS3
compared with CS1, supporting habituation of fear circuitry
activation over time, as found previously in both rodent and
human fear-conditioning fMRI studies (Brydges et al. 2013;
Buchel et al. 1998).
Although lateralisation of amygdala activation in response
to emotional processing appears to be consistently found
in both rodent and human fMRI studies (Brydges et al.
2013; Harris et al. 2015; LaBar et al. 1998; Pine et al. 2001)
reports of laterality must be supported by an explicit test
of the hemisphere-by-task interaction. In this experiment,
the activation maps suggested unilateral amygdala activa-
tion in response to the CS, however, a formal test of the
hemisphere-by-task interaction on the extracted parameter
estimates from the whole amygdala region did not support
this, as found previously in our laboratory in mice (Harris et al.
2015). Brydges et al. (2013) reported activation in the right
amygdala but did not formally test for laterality, therefore,
both sides may have been activated but below the statistical
threshold (as in this experiment).
In addition to the amygdala, we also found evidence of
activation in response to the CS in control animals of the
somatosensory cortex and granular insular cortex, both of
which can project to the BLA complex and form a compo-
nent of a pain processing pathway that is recruited into the
fear network in response to the CS (reviewed in McDonald
1998). We additionally observed activation in control animals
of the periaquaductal gray region, which receives direct pro-
jections from the CeA and is reported to play a role in process-
ing defensive behavior (e.g. freezing) (Behbehani 1995; Rizvi
et al. 1991) and the primary visual cortex and superior col-
liculus, which likely reﬂects visual processing of the stimulus
(Van Camp et al. 2006). Activation was also seen in controls
in the bed nucleus of the stria terminalis, which is a major
output pathway of the amygdala.
BDNF+/− rats showed a decreased behavioral response
(freezing) and decreased activation of the amygdala and
related fear processing circuitry in response to the CS in our
fMRI experiment (Korte et al. 1995; Minichiello et al. 1999).
These results demonstrate impaired amygdala-dependent
learning in these animals and show that in this model
reduced peripheral and central BDNF is associated with
impaired function of brain regions involved in processing
conditioned emotional stimuli (Endres & Lessmann 2012;
Korte et al. 1995; Minichiello et al. 1999). Foot-shock sensi-
tivity and the ability to detect visual cues (as tested in the
behavioral fear-conditioning experiment) were not impaired
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in the BDNF+/− rats, eliminating these factors as potential
confounds for the behavioral and imaging ﬁndings. Further-
more, unthresholded activation maps showed that visual pro-
cessing regions (visual cortex and superior colliculus; Van
Camp et al. 2006) were activated in response to the CS in
BDNF+/− and control rats (Fig. 3d). Although the visual acti-
vation in the BDNF+/− rats was below the statistical thresh-
old when corrected for multiple comparisons across the
whole brain, it was not signiﬁcantly different to that seen in
control rats.
Innate (i.e. unconditioned) anxiety, as tested on the ele-
vated plus maze, was not affected by reduced BDNF lev-
els in our experiment. This ﬁnding is consistent with the
results from previous studies using BDNF+/− rats and mice
(Endres & Lessmann 2012; Gururajana et al. 2014;MacQueen
et al. 2001; Montkowski & Holsboer 1997) and the percent-
age time spent in open arms (10%) is comparable with pre-
vious rat studies (Gururajana et al. 2014). Stress hormone
levels in response to the mild stress of elevated plus maze
testing were also unaltered in BDNF+/− rats. Similarly, cor-
ticosterone levels at resting and following 30min restraint
stress are reported to remain unaltered in BDNF+/− mice rela-
tive to controls (Chourbaji et al. 2003), these data along with
our ﬁndings suggest that reduced BDNF levels do not alter
HPA-axis reactivity or feedback. It is plausible that innate anx-
iety is not dependent on BDNF levels because it does not
require explicit new learning (unlike fear conditioning). These
data taken together with the fMRI data suggest that impaired
emotional learning, rather than altered innate anxiety and
HPA-axis reactivity, may accompany reduced BDNF levels in
human psychiatric disorders.
Emotional disorders such as depression, generalized anx-
iety disorder and PTSD in humans have been shown to be
associated with altered peripheral BDNF levels (Fernandes
et al. 2014;Matsuoka et al. 2013;Wang et al. 2015), and these
peripheral levels are in turn postulated to reﬂect central BDNF
signaling which is assumed to inﬂuence brain function. How-
ever, this hypothesis is challenging to test directly in humans.
Using genetically modiﬁed rats coupled with fMRI, we were
able to conﬁrm that baseline levels of BDNF in the amyg-
dala are a signiﬁcant predictor of amygdala function during
emotional processing. While we cannot directly conﬁrm that
serum levels correlated with amygdala function, we and oth-
ers (Klein et al. 2011; Pillai et al. 2010) report a strong cor-
relation between peripheral and central BDNF levels, and
therefore, we postulate that peripheral BDNF levels may be
a valid biomarker for BDNF action in the brain and brain func-
tion, at least in the context of genetic variation affecting the
BDNF gene.
In summary, BDNF+/− rats represent a model of impaired
plasticity across a range of neuropsychiatric conditions. We
show that BDNF+/− rats have reduced peripheral and central
BDNF levels that are associated with changes in brain acti-
vation during the processing of conditioned emotional stim-
uli. These results demonstrate, for the ﬁrst time, the use of
fMRI to detect altered fear processing in awake genetically
modiﬁed rats that are completing a learned emotional task.
The results also provide evidence for a relationship between
peripheral BDNF levels and emotional brain function, which is
of relevance to human biomarker research. We conclude that
awake fMRI with genetically modiﬁed rats provides a promis-
ing approach to screen potential biomarkers and therapies for
affective disorders in humans.
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corticosterone (CORT) levels immediately following testing
for control (n=10) and BDNF+/− rats (n=11).
Figure S1: Foot-shock sensitivity in control and BDNF+/−
rats. Behavioural score (± SEM) during shock titration. The
response of the rat was scored as follows: 0=no response;
1= slight ﬂinch; 2=ﬂinch/tail ﬂick; 3= fast walking around
chamber; 4= jumping up with all feet off the grid ﬂoor;
5= jumping upwith vocalization and fast walking. 0.8mAwas
used in the main experiment.
Figure S2: BDNF correlations. (a) There was a signiﬁ-
cant positive correlation between serum and hippocampus
BDNF levels [Pearson’s correlation coefﬁcient: r =0.86, 95%
CI (0.55, 0.96); P = 0.0004] and (b) therewas a signiﬁcant pos-
itive correlation between the extracted parameter estimates
from the functional left amygdala cluster and baseline amyg-
dala BDNF levels [measured 2weeks after fMRI; Pearson’s
correlation coefﬁcient r = 0.73, 95% CI for slope (0.3, 0.9);
P =0.0044].
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